Mark Westgate is listed as an executive officer and director on 4 SEC Form D filings by 2 issuers between Mar 2010 and Feb 2019: ThermoGenesis Holdings, Inc. (Rancho Cordova, CA — biotechnology — 2018–2019; $15M reported sold to 5 investors) and SEELOS THERAPEUTICS, INC. (New York, NY — biotechnology — 2010; $4M reported sold to 13 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $19M sold in total.
Listed alongside Vivian Liu (3 shared filings), Bassam Damaj (2 shared filings), Edward Cox (2 shared filings), Henry Esber (2 shared filings), James Xu (2 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Mark Westgate and found 6 differences: Form D filed 16 days after the first sale; Form D filed 17 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.